TG Therapeutics Announces FDA Approval of BRIUMVI™
BRIUMVI is the first and only anti-CD20 monoclonal antibody approved for patients with relapsing forms of multiple sclerosis that can be administered in a...
Source: globenewswire.com
Stay updated with breaking news from June Halper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BRIUMVI is the first and only anti-CD20 monoclonal antibody approved for patients with relapsing forms of multiple sclerosis that can be administered in a...
CRANBURY, N.J., June 03, 2022 (GLOBE NEWSWIRE) -- NeurologyLive® and the Consortium of Multiple Sclerosis Centers (CMSC) today announced the inaugural...